| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $301.7M | — | +48.3% |
| Cost of Revenue | $104.9M | — | +40.4% |
| R&D Expense | $91.0M | — | +2.8% |
| SG&A Expense | $57.9M | — | +23.4% |
| Operating Income | -$121.3M | — | -9.3% |
| Interest Expense | $1.3M | — | +70.3% |
| Pre-tax Income | -$111.7M | — | -17.7% |
| Income Tax | $372K | — | +28.3% |
| Net Income | -$112.1M | — | -17.8% |
| EPS (Basic) | -$0.85 | — | -10.4% |
| EPS (Diluted) | -$0.85 | — | -10.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $989.3M | +161.6% | +41.6% |
| Accounts Receivable | $137.4M | -0.3% | +19.0% |
| Inventory | $83.9M | -2.4% | +8.5% |
| Current Assets | $1.37B | -6.7% | +47.5% |
| Total Assets | $1.92B | -4.9% | +42.5% |
| Current Liabilities | $292.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$65.6M | — | -4.7% |
| Capital Expenditures | $5.6M | — | +25.1% |
| Investing Cash Flow | $699.4M | — | +130.9% |
| Financing Cash Flow | -$21.6M | — | +67.7% |
| Free Cash Flow | -$71.2M | — | -6.0% |
| +29.4% |
| Long-term Debt | $1.50B | -0.0% | +34.7% |
| Total Liabilities | $2.10B | -0.8% | +31.4% |
| Stockholders' Equity | -$181.1M | -82.3% | +27.8% |